CHI3L1 can directly stimulate tumor cells to produce proinflammatory cytokines (IL-6, IL-8, and transforming growth factor-β) and activate the transforming growth factor-β signaling pathway through binding to its receptor, resulting in proinflammatory cytokine production and immune cell recruitment. Here, IL6 is linked to neoplasm.